Singapore-Based A SPAC II Acquisition Prices US$185 Million IPO

Special purpose acquisition company A SPAC II Acquisition Corp. (Nasdaq: ASCBU) started trading on the Nasdaq Capital Market on Tuesday. The firm aims to raise US$185.0 million in its initial public offering.

The offering consisted of 18.5 million company units at US$10.00 per unit. Each unit contains one Class A common share, one-half of a redeemable warrant, and one-tenth of a right. Each whole warrant is exercisable for one common share at US$11.50 per share while each whole right equates to one common share upon business combination. The shares, warrants, and rights, once trading separately, will be trading under “ASCB”, “ASCBW”, and “ASCBR”, respectively.

Maxim Group acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 2.8 million units at the same IPO price.

The Singapore-based blank check firm intends to focus on completing a business combination in Proptech and Fintech, with particular preference to companies employing ESG principles.

Its predecessor A SPAC I Acquisition Corp. (Nasdaq: ASCAU) launched its US$60-million initial public offering in February 2022.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

Fintech SPAC SHUAA Partners Acquisition I Prices US$100 Million IPO

Special purpose acquisition company SHUAA Partners Acquisition Corp I (Nasdaq: SHUAU) started trading its securities...

Thursday, March 3, 2022, 02:27:00 PM

Tech Firm Actelis Networks Closes IPO, Raises US$16.9 Million

Networking solutions provider Actelis Networks (Nasdaq: ASNS) closed its initial public offering on the New...

Tuesday, May 24, 2022, 02:26:00 PM

Edtech Firm Genius Group Prices US$19.6 Million IPO

Edtech and education group Genius Group Limited (NYSE: GNS) began trading on the New York...

Tuesday, April 12, 2022, 02:19:00 PM